Management discusses the significant unmet medical need in surgical site infections and company update on the progress of D-PLEX Phase 3 Trial on a conference call to be held on June 17 at 10 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
- option delistings on June 3rd
- PolyPid Ltd. Schedules Shareholder Meeting
- PolyPid Enhances Share Option Plan to Motivate Staff
- PolyPid Advances Phase 3 Trial, Strengthens Finances